[1] P. Martin, R. Nunan, Cellular and molecular mechanisms of repair in acute and chronic wound healing, Br. J. Dermatol. 173 (2015), pp. 370–378
[2] A.J. Singer, R.A.F. Clark, Cutaneous wound healing, N. Engl. J. Med. 341 (1999), pp. 738–746
[3] H. Ito, T. Ando, H. Ogiso, Y. Arioka, K. Saito, M. Seishima, Inhibition of indoleamine 2,3-dioxygenase activity accelerates skin wound healing, Biomaterials. 53 (2015), pp. 221–228
[4] Y. Yamaguchi, K. Yoshikawa, Cutaneous wound healing: An update, J. Dermatol. 28 (2001), pp. 521–534
[5] H. Solberg, M. Ploug, G. Høyer-Hansen, B.S. Nielsen, L.R. Lund, The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling, J. Histochem. Cytochem. 49 (2001), pp. 237–246
[6] R.W. Stephens, J. Pollanen, H. Tapiovaara, K.C. Leung, P.S. Sim, E.M. Salonen, E. Ronne, N. Behrendt, K. Dano, A. Vaheri, Activation of pro-urokinase and plasminogen on human sarcoma cells: A proteolytic system with surface-bound reactants, J. Cell Biol. 108 (1989), pp. 1987–1995
[7] S. d’Alessio, L. Gerasi, F. Blasi, uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro, J. Cell Sci. 121 (2008), pp. 3922–3932
[8] C. Signor, C.F. Mello, G.P. Porto, D.A. Ribeiro, M.A. Rubin, Spermidine improves fear memory persistence, Eur. J. Pharmacol. 730 (2014), pp. 72–76
[9] H.C. Ha, N.S. Sirisoma, P. Kuppusamy, J.L. Zweier, P.M. Woster, R.A. Casero, The natural polyamine spermine functions directly as a free radical scavenger, Proc. Natl. Acad. Sci. U. S. A. 95 (1998), pp. 11140–11145
[10] H.K. Lim, A.B. Rahim, V.I. Leo, S. Das, T.C. Lim, T. Uemura, K. Igarashi, J. Common, L.A. Vardy, Polyamine Regulator AMD1 Promotes Cell Migration in Epidermal Wound Healing, J. Invest. Dermatol. 138 (2018), pp. 2653–2665
[11] A.E. Pegg, Functions of polyamines in mammals, J. Biol. Chem. 291 (2016), pp. 14904–14912
[12] N. Grandgirard, B. Ly-Sunnaram, D. Ferrant, V. Gandemer, C. Edan, E. Le Gall, J.P. Moulinoux, E. Leray, J.E. Goasguen, Impact of Topoisomerase II alpha and Spermine on the clinical outcome of children with acute lymphoblastic leukemia, Leuk. Res. 28 (2004), pp. 479–486
[13] H. Ito, A. Kanbe, H. Sakai, M. Seishima, Activation of NLRP3 signalling accelerates skin wound healing, Exp. Dermatol. 27 (2018), pp. 80–86
[14] Y. Mizutani, A. Kanbe, H. Ito, M. Seishima, Activation of STING signaling accelerates skin wound healing, J. Dermatol. Sci. 97 (2020), pp. 21–29
[15] C.M. Lo, D.B. Buxton, G.C.H. Chua, M. Dembo, R.S. Adelstein, Y.L. Wang, Nonmuscle Myosin IIB Is Involved in the Guidance of Fibroplast Migration, Mol. Biol. Cell. 15 (2004), pp. 982–989
[16] M. Zhu, V.M. Gokhale, L. Szabo, R.M. Munoz, H. Baek, S. Bashyam, L.H. Hurley, D.D. Von Hoff, H. Han, Identification of a novel inhibitor of urokinase-type plasminogen activator, Mol. Cancer Ther. 6 (2007), pp. 1348–1356
[17] V. Stepanova, K. V. Dergilev, K.R. Holman, Y. V. Parfyonova, Z.I. Tsokolaeva, M. Teter, E.N. Atochina-Vasserman, A. Volgina, S. V. Zaitsev, S.P. Lewis, F.G. Zabozlaev, K. Obraztsova, V.P. Krymskaya, D.B. Cines, Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors, J. Biol. Chem. 292 (2017), pp. 20528–20543
[18] P.J. Hohensinner, J. Baumgartner, J.B. Kral-Pointner, P. Uhrin, B. Ebenbauer, B. Thaler, K. Doberer, S. Stojkovic, S. Demyanets, M.B. Fischer, K. Huber, G. Schabbauer, W.S. Speidl, J. Wojta, PAI-1 (Plasminogen activator inhibitor-1) expression renders alternatively activated human macrophages proteolytically quiescent, Arterioscler. Thromb. Vasc. Biol. 37 (2017), pp. 1913–1922
[19] I.M. Freedberg, M. Tomic-Canic, M. Komine, M. Blumenberg, Keratins and the keratinocyte activation cycle, J. Invest. Dermatol. 116 (2001), pp. 633–640.
[20] N. Minois, D. Carmona-Gutierrez, F. Madeo, Polyamines in aging and disease, Aging (Albany. NY). 3 (2011), pp. 716–732
[21] S. Bardócz, T.J. Duguid, D.S. Brown, G. Grant, A. Pusztai, A. White, A. Ralph, The importance of dietary polyamines in cell regeneration and growth, Br. J. Nutr. 73 (1995), pp. 819–828
[22] T. Yamashita, K. Nishimura, R. Saiki, H. Okudaira, M. Tome, K. Higashi, M. Nakamura, Y. Terui, K. Fujiwara, K. Kashiwagi, K. Igarashi, Role of polyamines at the G1/S boundary and G2/M phase of the cell cycle, Int. J. Biochem. Cell Biol. 45 (2013), pp. 1042–1050
[23] M. Uszyński, M. Perlik, W. Uszyński, E. Zekanowska, Urokinase plasminogen activator (uPA) and its receptor (uPAR) in gestational tissues: Measurements and clinical implications, Eur. J. Obstet. Gynecol. Reprod. Biol. 114 (2004), pp. 54–58
[24] C. Wei, C.C. Möller, M.M. Altintas, J. Li, K. Schwarz, S. Zacchigna, L. Xie, A. Henger, H. Schmid, M.P. Rastaldi, P. Cowan, M. Kretzler, R. Parrilla, M. Bendayan, V. Gupta, B. Nikolic, R. Kalluri, P. Carmeliet, P. Mundel, J. Reiser, Modification of kidney barrier function by the urokinase receptor, Nat. Med. 14 (2008), pp. 55–63
[25] Y. Kanno, A. Kaneiwa, M. Minamida, M. Kanno, K. Tomogane, K. Takeuchi, K. Okada, S. Ueshima, O. Matsuo, H. Matsuno, The absence of uPAR is associated with the progression of dermal fibrosis, J. Invest. Dermatol. 128 (2008), pp. 2792–2797
[26] N. Sidenius, C.F.M. Sier, F. Blasi, Shedding and cleavage of the urokinase receptor (uPAR): Identification and characterisation of uPAR fragments in vitro and in vivo, FEBS Lett. 475 (2000), pp. 52–56
[27] M. Tjwa, N. Sidenius, R. Moura, S. Jansen, K. Theunissen, A. Andolfo, M. De Mol, M. Dewerchin, L. Moons, F. Blasi, C. Verfaillie, P. Carmeliet, Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells, J. Clin. Invest. 119 (2009), pp. 1008–1018
[28] F. Furlan, S. Orlando, C. Laudanna, M. Resnati, V. Basso, F. Blasi, A. Mondino, The soluble D2D388-274 fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion, J. Cell Sci. 117 (2004), pp. 2909–2916
[29] F. Cooper, A.M. Overmiller, A. Loder, D.M. Brennan-Crispi, K.P. McGuinn, M.R. Marous, T.A. Freeman, N.A. Riobo-Del Galdo, L.D. Siracusa, J.K. Wahl, M.G. Mahoney, Enhancement of Cutaneous Wound Healing by Dsg2 Augmentation of uPAR Secretion, J. Invest. Dermatol. 138 (2018), pp. 2470–2479
[30] L. Zhang, D.K. Fogg, D.M. Waisman, RNA Interference-mediated Silencing of the S100A10 Gene Attenuates Plasmin Generation and Invasiveness of Colo 222 Colorectal Cancer Cells, J. Biol. Chem. 279 (2004), pp. 2053–2062
[31] Y. Zhao, C.E. Lyons, A. Xiao, D.J. Templeton, Q.A. Sang, K. Brew, I.M. Hussaini, Urokinase directly activates matrix metalloproteinases-9: A potential role in glioblastoma invasion, Biochem. Biophys. Res. Commun. 369 (2008), pp. 1215–1220
[32] H. Matthews, M. Ranson, J.D.A. Tyndall, M.J. Kelso, Synthesis and preliminary evaluation of amiloride analogs as inhibitors of the urokinase-type plasminogen activator (uPA), Bioorganic Med. Chem. Lett. 21 (2011), pp. 6760–6766
[33] A.A. Reinke, S.H. Li, M. Warnock, M.E. Shaydakov, N.S. Guntaka, E.J. Su, J.A. Diaz, C.D. Emal, D.A. Lawrence, Dual-reporter high-throughput screen for small-molecule in vivo inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidate, J. Biol. Chem. 294 (2019), pp. 1464–1477
[34] S.A. Eming, P. Martin, M. Tomic-canic, H. Park, R. Medicine, Wound repair and regeneration: Mechanisms, signaling, and translation Sabine, Sci Transl Med. 6 (2016), pp. 1–36
[35] G. Li, H. Ding, X. Yu, Y. Meng, J. Li, Q. Guo, H. Zhou, N. Shen, Spermidine Suppresses Inflammatory DC Function by Activating the FOXO3 Pathway and Counteracts Autoimmunity, IScience. 23 (2020), Article 100807
[36] R. Amendola, M. Cervelli, E. Fratini, D.E. Sallustio, G. Tempera, T. Ueshima, P. Mariottini, E. Agostinelli, Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments, Int. J. Oncol. 43 (2013), pp.813–820
[37] Á. Horváth, A. Menghis, B. Botz, É. Borbély, Á. Kemény, V. Tékus, J.Z. Csepregi, A. Mócsai, T. Juhász, R. Zákány, D. Bogdán, P. Mátyus, J. Keeble, E. Pintér, Z. Helyes, Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse, Sci. Rep. 7 (2017), pp.1–13
[38] S. Wang, X. Song, K. Zhang, S. Deng, P. Jiao, M. Qi, Z. Lian, Y. Yao, Overexpression of Toll-Like Receptor 4 Affects Autophagy, Oxidative Stress, and Inflammatory Responses in Monocytes of Transgenic Sheep, Front. Cell Dev. Biol. 8 (2020), pp.1–14
[39] R.M. Gallucci, P.P. Simeonova, J.M. Matheson, C. Kommineni, J.L. Guriel, T. Sugawara, M.I. Luster, Impaired cutaneous wound healing in interleukin‐6‐deficient and immunosuppressed mice, FASEB J. 14 (2000), pp.2525–2531
[40] A. Tang, B.A. Gilchrest, Regulation of keratinocyte growth factor gene expression in human skin fibroblasts, J. Dermatol. Sci. 11 (1996), pp.41–50